At Alexion, we are explorers, transformers, innovators and adventurers. And at the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for patients.
One Patient at a Time
Alexion's intimate patient connection is driven by our focus on devastating and rare diseases. We discover, develop and deliver treatment options for patients who have heard “no” for far too long. For this small pool of individuals, we may be their last hope. Here, we understand patients' stories, their families, their struggles and their successes. Our mission to deliver medical breakthroughs is propelled by our commitment to transform lives – we push ourselves every day so that patients can finally hear “yes.”
Alexion's unwavering commitment to breakthrough innovation isn't a choice, it's a necessity. We engineer our own path because the scientific challenges we choose to tackle require it, and our patients' lives depend on it. We are incredibly proud that our work has been recognized globally through some of the industry's highest honors, including the Prix Galien Award for Soliris® (eculizumab) and Kanuma® (sebelipase alfa), and recognition on Forbes' “World's Most Innovative Companies” list for five consecutive years. Learn more about our award-winning drugs and pipeline.